Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017901 |
---|---|
Receipt number | R000020539 |
Scientific Title | Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the Treatment of Male Stress Urinary Incontinence |
Date of disclosure of the study information | 2015/07/01 |
Last modified on | 2019/11/13 13:56:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/06/14 17:12:04 | ||
2 | Update | 2015/09/02 10:51:45 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
3 | Update | 2015/09/02 11:10:21 | Recruitment status Anticipated trial start date |
|
4 | Update | 2016/01/14 17:38:24 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2016/01/14 18:02:45 | Last name of contact person Last name of contact person Division name Division name TEL |
|
6 | Update | 2016/05/10 15:47:09 | Name of primary person or sponsor Institute Department Organization Organization Category of Funding Organization |
|
7 | Update | 2016/12/14 09:27:49 | Key inclusion criteria |
|
8 | Update | 2016/12/14 09:28:55 | Last name of contact person Last name of contact person |
|
9 | Update | 2017/12/14 19:21:36 | URL releasing protocol |
|
10 | Update | 2018/03/28 12:02:37 | Recruitment status Last follow-up date |
|
11 | Update | 2018/12/10 18:18:02 | Date trial data considered complete Date analysis concluded |
|
12 | Update | 2019/06/17 09:21:55 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code TEL Organization Organization Address Address Tel |
|
13 | Update | 2019/06/17 09:22:45 | Number of participants that the trial has enrolled |
|
14 | Update | 2019/06/17 09:24:35 | Date of IRB |
|
15 | Update | 2019/11/13 13:56:57 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |